CRESCO LABS Aktie

 

Workers Secure Better Wages, Health Care, and Improved Working Conditions WYOMISSING, Pa., March 26, 2026 /PRNewswire/ -- After 20 days on strike, Teamsters Local 429 members at Sunnyside Dispensary have secured a new contract. Sunnyside is a subsidiary of Cresco Labs, a publicly traded......

Cresco Labs Inc. (CRLBF) delivered earnings and revenue surprises of +14.16% and +0.26%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?...

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the fourth quarter ended and year ended December 31, 2025. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company's investor website, here. Fiscal Year 2025 Highlights Revenue of $656 million. Operating cash flow of $73 million and Free Cash Flow1 of $38 million. Gross profit of $325 million. Adjusted gross profit1 of $329 million; and an Adjusted gross margin1 of 50.2%. SG&A of $218 million. Reduced Adjusted SG&A1 by 5.7% year-over-year to $200 million, or 30.4%. Net loss of $140 million, which includes one-time, non-cash charges of $105 million related to the Company's i...

Workers Demand Fair Wages, Stable Hours, and Respect WYOMISSING, Pa., Feb. 26, 2026 /PRNewswire/ -- Teamsters at the Sunnyside dispensary in Wyomissing, Pennsylvania voted unanimously to authorize a strike after the company failed to present a contract that fairly compensates its workers.......

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the full year and quarter ended December 31st, 2025 on Thursday, March 5, 2026 before the market opens. The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights. Event: Cresco Labs Fourth Quarter 2025 Earnings Conference Call Date: Thursday, March 5, 2026 Time: 8:30 am ET Webcast: LINKConference Call Registration: LINKDial-in: 1-833-470-1428 (US Toll Free), 1-646-844-6383 (US Local) Access Code: 152399 Archived access to the webcast will be available for one year on the Cresco Labs investor relations website. About Cresco Labs Inc. Cresco Labs' mission is to normalize and professionalize the cannabis industry through a CPG ap...

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

Tilray Brands' global expansion and strong Canadian momentum spotlight its edge as investors weigh upside against Cresco Labs' slower growth....

Cresco Labs Inc. (CRLBF) delivered earnings and revenue surprises of -66.67% and +0.71%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?...

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the third quarter ended September 30, 2025. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company's investor website, here. Third Quarter 2025 Highlights Third quarter revenue of $165 million. Third quarter operating cash flow of $6 million. Gross profit of $79 million. Adjusted gross profit1 of $80 million; and an Adjusted gross margin1 of 48.8%. SG&A of $52 million or 31.3% of revenue. Net loss of $22 million, includes a $16 million loss for debt extinguishment related to the refinancing of the Company's senior secured term loan, and non-cash impairment charges of $2 mi...

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the third quarter ended September 30th, 2025 on Wednesday, November 5, 2025 before the market opens. The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights. Event: Cresco Labs Third Quarter 2025 Earnings Conference Call Date: Wednesday, November 5, 2025 Time: 8:30 am ET Webcast: LINKConference Call Registration: LINKDial-in: 1-833-470-1428 (US Toll Free), 1-646-844-6383 (US Local) Access Code: 307245 Archived access to the webcast will be available for one year on the Cresco Labs investor relations website. About Cresco Labs Inc. Cresco Labs' mission is to normalize and professionalize the cannabis industry through a CPG ap...

Toronto, Ontario--(Newsfile Corp. - September 29, 2025) - The following CSE-Listed symbol will become MOC Eligible as detailed below. Symbol Company Name Effective Date CL Cresco Labs Inc. - Subor......

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the results of its annual general and special meeting of shareholders (the “Meeting”) held on September 16, 2025. At the Meeting, the number of directors of the Company for the ensuing year was fixed at seven (7) and the following nominees for election as directors of the Company were elected by a majority of votes cast by the shareholders virtually present or represented by proxy at the Meeting: Charles Bachtell Gerald F. Corcoran Robert M. Sampson Thomas J. Manning Marc Lustig Michele Roberts Randy D. Podolsky  In addition, Baker Tilly US, LLP was appointed as the Company's auditor for the ensuing year. Shareholders also voted to approve the Company's Award Exchange Program (the “Award Exchange”). Under the Award Exchange, certain employees were given the option to exchange certain underwater options for a like number of full value awards with new three-year...

Transaction Extends Maturity to 2030, Strengthens Balance Sheet and Positions Company for GrowthCHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the closing of its previously announced refinancing of the Company's senior secured credit facility. The new US$325 million senior secured term loan bears an interest rate of 12.5% per annum and matures on August 13, 2030. It replaces the Company's prior US$360 million facility, reducing total debt, extending the maturity to 2030, and providing enhanced flexibility to prepay up to US$125 million at a reduced premium. “This transaction is another milestone in our disciplined approach to capital management,” said Charlie Bachtell, CEO of Cresco Labs. “We have strengthened our balance sheet and removed near-term refinancing risk. With this foundation in place, we can remain focused on executing our growth strategy.” Proceeds from the new facility, together with cash on ...

Cresco Labs Inc. (CRLBF) delivered earnings and revenue surprises of -25.00% and -0.15%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?...

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

 CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the second quarter ended June 30, 2025. All financial information presented in this release is reported in accordance with U.S. GAAP and in U.S. dollars, unless otherwise indicated, and is available on the Company's investor website, here. Second Quarter 2025 Highlights Second quarter revenue of $164 million. Second quarter operating cash flow of $9 million. Gross profit of $83 million. Adjusted gross profit1 of $83 million; and an Adjusted gross margin1 of 50.6% of revenue. SG&A of $51 million or 31.4% of revenue. Net loss of $14 million, includes non-cash impairment charges of $9 million related to California assets being considered held for sale. Second quarter Adjusted EBITDA1 of $41 ...

Will Reduce Debt and Reinforces Commitment to Prudent Capital ManagementCHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced that it has successfully obtained commitments to refinance its senior secured credit facility (the “Senior Loan”). The refinancing, upon closing, will provide for a new senior secured term loan totaling US$325 million, bearing an interest rate of 12.5% per annum, and maturing on the 5th year anniversary of the closing of the refinancing. The new facility will replace the Company's existing US$360 million credit facility, providing enhanced financial flexibility and favorable terms, including provisions that will allow for the prepayment of up to US$125 million at a reduced prepayment premium. The refinancing comes at a time when access to capital remains highly constrained across the U.S. cannabis sector. With an estimated $2 billion in industry debt maturities coming due over the next 18 months...